Drug Patents owned by Aaa Usa Inc

1. List of Lutathera drug patents

LUTATHERA Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10596276 AAA USA INC Stable, concentrated radionuclide complex solutions
Jul, 2038

(15 years from now)

US10596278 AAA USA INC Stable, concentrated radionuclide complex solutions
Jul, 2038

(15 years from now)

Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Jan 26, 2023
Orphan Drug Exclusivity (ODE) Jan 26, 2025

Drugs and Companies using LUTETIUM DOTATATE LU-177 ingredient

NCE-1 date: 2022-01-26

Market Authorisation Date: 26 January, 2018

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

LUTATHERA family patents

10

United States

4

Japan

4

European Union

IB

3

IB

3

China

2

Australia

1

Israel

1

Germany

1

Colombia

1

Argentina

1

Brazil

1

Singapore

1

Canada

1

Korea, Republic of

1

Taiwan, Province of China

2. List of Netspot drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9375498 AAA USA INC Process for the preparation of complexes of 68Ga
Aug, 2032

(9 years from now)

Exclusivity Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Jun 1, 2023

Drugs and Companies using GALLIUM DOTATATE GA-68 ingredient

Market Authorisation Date: 01 June, 2016

Treatment: NA

Dosage: POWDER;INTRAVENOUS

More Information on Dosage

NETSPOT family patents

4

European Union

3

Israel

3

Russia

3

United States

2

Brazil

2

Spain

2

Canada

2

New Zealand

1

South Africa

1

Denmark

1

Mexico

1

Australia

1

Colombia

1

Portugal

1

Italy

1

Poland

1

India

1

China

1

Japan

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in